Abbott Laboratories
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Asset Breakdown FY2023
Total Assets: $73.21B
Liabilities Breakdown FY2023
Total Liabilities: $34.61B
Asset Breakdown
Total Assets: $73.21B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $6.90B | 9.4% |
| Accounts Receivable | $6.57B | 9.0% |
| Inventory | $6.57B | 9.0% |
| Property, Plant & Equipment | $10.15B | 13.9% |
| Goodwill | $23.68B | 32.3% |
| Intangible Assets | $8.82B | 12.0% |
| Other Assets | $10.54B | 14.4% |
Liabilities Breakdown
Total Liabilities: $34.61B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.30B | 12.4% |
| Long-Term Debt | $13.60B | 39.3% |
| Other Liabilities | $16.72B | 48.3% |